Armonica is an medtech focused on developing its proprietary long-read DNA sequencing technology for precision medicine applications.
Armonica Technologies derives its name from prolific innovator Benjamin Franklin’s favorite invention, The Glass Armonica. Armonica Technologies is an early stage medtech company focused on developing its proprietary long-read DNA sequencing technology for precision medicine applications. The Company’s technology is based upon a portfolio of patented and patent pending technologies licensed from STC.UNM.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 31, 2022 | Grant | $2M | 1 | National Human Genome Research Institute | — | Detail |
Mar 29, 2021 | Grant | $350K | 1 | National Human Genome Research Institute | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Human Genome Research Institute | Yes | Grant |